 |
Once-weekly
exenatide jab for diabetes |
| |
This study provides encouraging results for
the once-weekly exenatide injections, which may eventually provide
a more convenient treatment regimen for patients with type 2 diabetes
than the current standard twice-daily regimen. There are a few
limitations to consider: (Behind the Headlines - NHS Choices, UK) |
| |
|
|
Exenatide
Once Weekly Versus Twice Daily for the Treatment of Type 2 Diabetes |
| |
Exenatide, an incretin mimetic, has glucoregulatory
properties similar to those of GLP-1 (glucagon-like peptide 1).
Exenatide has been shown to enhance glycemic control when administered
twice a day in patients with type 2 diabetes (American Diabetes
Association) |
| |
|
|
Primary
Care Diabetes |
| |
Contents for September issue of (Primary Care
Diabetes) |
| |
|
|
Diabetes
self-management education: A review of published studies |
| |
There is a growing body of literature on both
educational and psychosocial interventions, aimed at helping individuals
to better manage their diabetes ... This paper aims to further
clarify this literature by considering published evidence for the
effectiveness of self-management education, including community-based
peer support groups and ongoing home telephone support (Primary
Care Diabetes) |
| |
|
|
The “metabolic
syndrome” is less useful than random plasma glucose to screen for glucose intolerance |
| |
MetS features can be used to identify risk of
diabetes, but predictive usefulness is driven largely by FPG. Overall,
to identify diabetes or prediabetes in blacks and whites with varying
age and BMI, MetS is no better than RPG—a more convenient and less expensive test (Primary Care Diabetes) |
| |
|
|
Professional
members' webspace |
| |
The new password protected area is an exciting
addition to the professional membership benefits package and offers
an exclusive access to a range of resources (Diabetes UK) |
| |
|
|
Continuous
glucose monitoring may improve outcomes in adults with type 1
diabetes |
| |
Continuous blood glucose monitoring may improve
glycaemic control in adults, according to a controlled trial, although
it did not seem to have benefits in children and adolescents (National
Electronic Library for Medicines, UK) |
| |
|
|
Introduction
of a new incentive and target-based contract for family physicians
in the UK: good for older patients with diabetes but less good
for women? |
| |
The introduction of the nGMS contract was associated
with a rise in the recording of patients with diabetes and the
recording of diabetes-related quality indicators. However, women
have not benefited equally from the nGMS contract (Diabetic Medicine) |
| |
|
|
Peer
advisers compared with specialist health professionals in delivering
a training programme on self-management to people with diabetes |
| |
Trained patients are as effective in imparting
knowledge to their peers as specialist health professionals. Both
are also acceptable to patients as trainers (Diabetic Medicine) |
| |
|
|
B-MS
and AstraZeneca's Onglyza improves glucose control |
| |
Bristol-Myers Squibb and AstraZeneca have presented
promising data from two late-stage studies for their investigational
type 2 diabetes compound saxagliptin (PharmaTimes) |
| |
|
|
Novo
Nordisk set to IMPROVE diabetes outlook |
| |
Novo Nordisk's NovoMix 30 significantly improves
blood glucose control in type-2 diabetes patients new to insulin,
whether or not they have previously received treatment with oral
antidiabetes drugs, according to results from IMPROVE, the largest-ever
observational study in the disease (PharmaTimes) |
| |
|
|
Sector
Snap: Diabetes drug developers |
| |
Shares of several diabetes drug developers received
a slight boost Tuesday as companies including Eli Lilly & Co. and Merck & Co. touted the effectiveness of their respective treatments in an already highly
competitive market (CNN, USA) |
| |
|
|
Oramed
Pharmaceuticals Partners with ETI Karle Clinical to Conduct Phase
2B Trials on Its Oral Insulin Capsule, ORMD 0801 |
| |
Oramed Pharmaceuticals, Inc. a developer of
oral delivery systems, announced today the signing of an agreement
with ETI Karle Clinical Pvt. Ltd., a clinical research organization
located in India, to conduct Phase 2B clinical trials on its oral
insulin capsules (Oramed Pharmaceuticals) |
| |
|
|
Over
1 in 5 Affluent Indians Have Type 2 Diabetes Mellitus |
| |
Researchers from north India report that 21.1%
of affluent adults have type 2 diabetes, the highest figures from
India so far (Reuters) |
| |
|
|
ADVANCE:
Intensive glucose, BP lowering therapy is safe, tolerated |
| |
Combining intensive glucose control using gliclazide
with intensive blood pressure lowering using a fixed combination
of perindopril and indapamide reduced the risk of cardiovascular
events, mortality and kidney complications in patients with type
2 diabetes (Endocrine Today) |
| |
|
|
Texas
Type 2 Diabetes Report |
| |
The 2008 Texas Type 2 Diabetes Report helps
TBGH fulfill its mission to help Texas employers play an active
and enthusiastic role in collaboration with health plans, providers
and purchasers; and be a catalyst in promoting costeffective delivery
of quality health care to the benefit of the community . 24-page
PDF (Texas Business Group on Health) |
| |
|
|
German
diabetes risk management study begins |
| |
A new collaborative research project has been
launched in Germany to examine how computer technology can be used
to help predict risk factors associated with diabetes (Health Europe) |
| |
|
|
Men's
Health Campaign Launched |
| |
American Diabetes Association Survey Identifies
Issues Every Man With Diabetes Should Know-Men's Health Campaign
Launched to Address Often Overlooked Physical, Emotional and Sexual
Issues Affecting Men With Diabetes (American Diabetes Association) |
| |
|
|
Scientists
call for huge increase in gastric bypass surgery to tackle obesity
crisis |
| |
Controversial surgery for treating obesity that
involves reducing the patient's stomach to the size of a thumb
should be more widely available on the NHS, according to researchers
(Guardian, UK) |
| |
|
|
Receptor
activation protects retina from diabetes destruction |
| |
A drug known for it pain-relieving power and
believed to stimulate memory appears to prevent this retinal damage
that leads to vision loss (Biology News Net) |
| |
|
